• Citer

Evaluation of PI3K-pathway–activation status in matched primary (P) and metastatic (M) ER+/HER2- breast cancer (BC) lesions according to PIK3CA-mutation status.

par Fumagalli, Debora ;Jose, Vinu ;Salgado, Roberto;Michiels, Stefan ;Wilson, TR;O'Brien, CO;HUW, L;Rouas, Ghizlane;Criscitiello, Carmen ;Pugliano, Lina ;Piccart-Gebhart, Martine ;Lackner, MR;Loi, Sherene ;Sotiriou, Christos
Référence ASCO Annual Meeting 2014 (May 30 - June 3, 2014: Chicago, Il, USA)
Publication Non publié, 2014

Poster de conférence

• Détails
• Contenu

Résumé :

J Clin Oncol 32:5s, 2014 - suppl; abstr 11060